A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

JOHANNESBURG, Feb 18 (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order ...

Trump's Aid Cuts Stop South African HIV Vaccine Trials in Their Tracks By Nellie Peyton JOHANNESBURG (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, ...

Understanding how ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus.

Last month, researchers in South Africa were preparing to administer two experimental HIV vaccines in a Phase 1 clinical trial. The staff was trained, immunizations were ready, and participant ...